Article Information
History
- September 25, 2020.
Article Versions
- Version 1 (June 5, 2020 - 10:39).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Marco Antônio M. Pretti1,2,
- Rômulo G. Galvani1,3,4,
- Gustavo Fioravanti Vieira5,6,
- Adriana Bonomo4,7,
- Martín H. Bonamino2,7 and
- Mariana Boroni1,*
- 1Laboratory of Bioinformatics and Computational Biology, Division of Experimental and Translational Research, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil
- 2Immunology and Tumor Biology Program - Research Coordination, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil
- 3Universidade Veiga de Almeida, Rio de Janeiro, Brazil
- 4Laboratory for Thymus Research (LPT), Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil
- 5Laboratory of Immunoinformatics (NBLI), Department of Genetics, Institute of Biosciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
- 6Laboratory of In Silico Human Health, Post Graduate Program in Health and Human Development, La Salle University, Canoas, Brazil
- 7Vice-Presidency of Research and Biological Collections (VPPCB), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil
- ↵*Correspondence:
Corresponding Author mariana.boroni{at}inca.gov.br
Posted September 25, 2020.
Class I HLA allele predicted antigenic coverages for Spike and Nucleocapsid proteins are associated with deaths related to COVID-19
